Published in Lancet on May 08, 2010
HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer (2011) 1.16
Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol (2014) 0.94
Incidence and trends in Burkitt lymphoma in northern Tanzania from 2000 to 2009. Pediatr Blood Cancer (2012) 0.92
Burkitt Lymphoma: beyond discoveries. Infect Agent Cancer (2013) 0.91
Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Clin Epidemiol (2012) 0.85
A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer (2012) 0.82
Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa. J Acquir Immune Defic Syndr (2014) 0.80
Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40
Statics and dynamics of malaria infection in Anopheles mosquitoes. Malar J (2004) 4.65
Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med (2006) 4.46
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33
The risk of a mosquito-borne infection in a heterogeneous environment. PLoS Biol (2004) 3.46
Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis (2010) 2.90
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ (2009) 2.84
Time trends in cancer mortality in China: 1987-1999. Int J Cancer (2003) 2.67
The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J (2009) 2.66
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials (2007) 2.63
Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? Lancet Infect Dis (2009) 2.46
Ross, macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens. PLoS Pathog (2012) 2.38
Sources of variability in determining malaria parasite density by microscopy. Am J Trop Med Hyg (2005) 2.34
An elaborated feeding cycle model for reductions in vectorial capacity of night-biting mosquitoes by insecticide-treated nets. Malar J (2007) 2.33
A simulation model of African Anopheles ecology and population dynamics for the analysis of malaria transmission. Malar J (2004) 2.29
Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J (2004) 2.29
Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg (2008) 2.29
Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer (2006) 2.25
Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer (2003) 2.13
The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission. Malar J (2005) 1.93
Increasing malaria hospital admissions in Uganda between 1999 and 2009. BMC Med (2011) 1.92
Mobile phone text messaging: tool for malaria control in Africa. PLoS Med (2012) 1.88
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J (2011) 1.73
Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med (2006) 1.72
Reader technique as a source of variability in determining malaria parasite density by microscopy. Malar J (2006) 1.68
Research on stored biological samples: the views of Ugandans. IRB (2005) 1.59
Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J (2010) 1.49
Systematic comparison of two methods to measure parasite density from malaria blood smears. Parasitol Res (2006) 1.40
Environmental factors associated with the malaria vectors Anopheles gambiae and Anopheles funestus in Kenya. Malar J (2009) 1.36
Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events. Trop Med Int Health (2008) 1.31
Impregnated netting slows infestation by Triatoma infestans. Am J Trop Med Hyg (2008) 1.29
Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria. Malar J (2007) 1.29
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J (2008) 1.27
Parasite prevalence: a static measure of dynamic infections. Am J Trop Med Hyg (2007) 1.27
Age-structured red blood cell susceptibility and the dynamics of malaria infections. Proc Natl Acad Sci U S A (2004) 1.25
The spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994-2006. Malar J (2009) 1.25
Practical implications of imposing a new world standard population. Cancer Causes Control (2002) 1.22
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty. Malar J (2010) 1.20
The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J (2005) 1.18
Diagnosis and treatment of malaria. BMJ (2007) 1.07
Community and facility-level engagement in planning and budgeting for the government health sector--a district perspective from Kenya. Health Policy (2010) 1.07
Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol (2007) 1.06
Nigeria Anopheles vector database: an overview of 100 years' research. PLoS One (2011) 1.05
Host control of malaria infections: constraints on immune and erythropoeitic response kinetics. PLoS Comput Biol (2008) 1.05
Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Malar J (2008) 1.02
Cancer incidence in a rural population of South Africa, 1998-2002. Int J Cancer (2010) 1.01
Ecological theory to enhance infectious disease control and public health policy. Front Ecol Environ (2005) 0.99
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med (2015) 0.99
Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006. Int J Cancer (2010) 0.99
Spatial patterns in discordant diagnostic test results for Chagas disease: links to transmission hotspots. Clin Infect Dis (2009) 0.98
African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg (2011) 0.97
Coupling ecology and evolution: malaria and the S-gene across time scales. Math Biosci (2004) 0.96
Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda. Antimicrob Agents Chemother (2010) 0.96
Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol (2012) 0.96
Link between immune response and parasite synchronization in malaria. Proc Natl Acad Sci U S A (2003) 0.95
Rational spatio-temporal strategies for controlling a Chagas disease vector in urban environments. J R Soc Interface (2010) 0.95
Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children. PLoS One (2013) 0.95
Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria. J Infect Dis (2003) 0.94
Competition for red blood cells can enhance Plasmodium vivax parasitemia in mixed-species malaria infections. Am J Trop Med Hyg (2006) 0.93
Caregivers' perceived treatment failure in home-based management of fever among Ugandan children aged less than five years. Malar J (2006) 0.92
Helicobacter pylori and cancer among adults in Uganda. Infect Agent Cancer (2006) 0.89
Host immune constraints on malaria transmission: insights from population biology of within-host parasites. Malar J (2013) 0.85
Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana. Int J Cancer (2011) 0.83
Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer. Genet Test (2006) 0.83
A case-control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls? Infect Agent Cancer (2012) 0.82
Developmental allometry and paediatric malaria. Malar J (2012) 0.82
Population-based incidence estimates of uveal melanoma in Germany. Supplementing cancer registry data by case-control data. Eur J Cancer Prev (2006) 0.81
Dynamics of immune response and drug resistance in malaria infection. Malar J (2006) 0.79
Factors Affecting Health-Related Quality of Life in Patients With Cholangiocarcinoma in the Northeastern Region of Thailand. Cancer Nurs (2015) 0.79
Foetal haemoglobin and the dynamics of paediatric malaria. Malar J (2012) 0.78
A stochastic model of immune-modulated malaria infection and disease in children. Math Biosci (2007) 0.77
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med (2008) 0.75
Intermittent preventive malaria treatment in Tanzanian infants. Lancet (2005) 0.75
Dopamine agonists and valvular heart disease. N Engl J Med (2007) 0.75
Crisis in the physician-patient relationship. Med World News (1976) 0.75